Pere Domingo-Pedrol, Medical Doctor

Hospital Universitario de la Santa Creu i Sant Pau, Spain

Disclosure(s): Gilead: Advisor/Consultant, Honoraria; Janssen: Advisor/Consultant, Honoraria; MSD: Advisor/Consultant, Honoraria; ViiV: Advisor/Consultant, Honoraria

Poster(s):

• (P-539) Does Switching from Triple (or Quadruple)-Drug Regimen to Double-Drug Regimen with Oral INSTIs Reduce Drug-Related Adverse Events (DRAEs) and Toxicity in Virologically Suppressed People with HIV? SATISFACTION Study
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT